Go, Jay-ann C.

HRN: 18-94-74  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/24/2022
CEFUROXIME 750MG (VIAL)
08/24/2022
08/31/2022
IV
750mg
Q8
S/P Primary CS
08/25/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/25/2022
08/31/2022
IV
500mg
Q8
Thicky MSAF
Waiting Final Action 
08/26/2022
CEFTAZIDIME 1GM (VIAL)
08/26/2022
09/02/2022
IV
1g
Q8
Pneumonia - Severe; COVID Suspect
Waiting Final Action 
08/26/2022
AZITHROMYCIN 500MG TABLET (TAB)
09/02/2022
09/02/2022
PO
500mg
OD
Pneumonia; Covid Suspect
Waiting Final Action 
08/30/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/30/2022
09/06/2022
IV
3gm
Q6
Wound Dehiscence, S/p Primary LTCS
Waiting Final Action 
08/30/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/30/2022
09/06/2022
IV
500mg
Q8
Wound Dehiscence, S/p Primary LTCS
Waiting Final Action 
09/01/2022
METRONIDAZOLE 500MG (TAB)
09/01/2022
09/06/2022
PO
500 Mg
TID
TMSAF
Waiting Final Action 
09/01/2022
METRONIDAZOLE 500MG (TAB)
09/01/2022
09/08/2022
PO
500mg
TID
Wound Dehiscence
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: